Avantor, Inc. reports developments as a life science tools company supplying mission-critical products and services to life sciences and advanced technology customers through its VWR Distribution & Services and Bioscience & Medtech Products businesses. Recurring updates cover earnings, cash flow, leverage, guidance, segment performance and the company’s Revival transformation program, including VWR brand activity, manufacturing and supply-chain improvements and e-commerce upgrades.
Company news also covers portfolio and infrastructure actions such as Masterflex fluid handling systems, single-use assemblies, peristaltic pumps, J.T. Baker high-purity process chemicals, and expanded microbial and stability testing capabilities for regulated biopharma manufacturing. Governance and management updates include finance leadership changes and appointments tied to bioscience, medtech products and enterprise transformation.
Avantor, Inc. (NYSE: AVTR) announced a multi-year investment to enhance its global hydration capabilities, completing a significant facility expansion in Gliwice, Poland, and initiating further expansion in Aurora, Ohio, projected to finish by mid-2022. This investment aims to support the biopharmaceutical industry's increasing demand for biologics by outsourcing buffer preparation, which can streamline workflows and accelerate therapy production. The expanded facilities will improve Avantor's ability to offer WFI-quality water buffer manufacturing, enhancing support for biopharma manufacturers globally.
Avantor, a global leader in mission-critical products for various industries, announced a virtual investor day scheduled for September 9, 2021, at 9:00 a.m. EDT. The event will be accessible via webcast on their official website, where a replay will also be available post-event. Avantor serves over 225,000 customer locations globally, impacting research and production across biopharma, healthcare, education, and advanced technology sectors. The company emphasizes forward-looking statements, cautioning that these may involve risks and uncertainties.
Avantor, Inc. (NYSE: AVTR) reported robust financial results for Q2 2021, with net sales of $1.86 billion, up 25.7% year-on-year. Net income surged 162.1% to $157.8 million. The company achieved 34.2% growth in Adjusted EBITDA to $366.6 million, with a margin expansion of 125 basis points. Despite two acquisitions, Ritter GMBH and RIM Bio, having no significant impact on quarterly results, the company raised its full-year guidance, reflecting confidence in ongoing momentum across various markets.
Summary not available.
Avantor (NYSE: AVTR) announced a quarterly cash dividend of $0.78 per share for its 6.250% Series A Mandatory Convertible Preferred Stock, translating to a rate of 1.560%. This dividend is payable on August 16, 2021 to shareholders of record as of August 1, 2021. As a leading global provider of essential products and services across life sciences and technology sectors, Avantor's substantial footprint serves over 225,000 customer locations in more than 180 countries, underscoring its influence in critical research and development activities.
Avantor, Inc. (NYSE: AVTR) has announced a change in the schedule for its second quarter 2021 earnings release. The financial results will now be disclosed after market close on July 29, 2021, followed by a conference call on July 30, 2021, at 7:30 a.m. EDT. Interested participants can join the call by dialing (866) 211-4132 domestically or (647) 689-6615 internationally. A live webcast will be available on the company’s investor webpage, with a replay accessible until August 28, 2021.
Avantor, Inc. (NYSE: AVTR), a global provider of essential products and services, will release its Q2 2021 financial results after market close on July 28, 2021. The company will host a conference call at 5:00 p.m. EDT to discuss these results. Interested participants can join via phone or through a live webcast on Avantor's investor website. The earnings press release and presentation will also be available. Avantor serves over 225,000 customer locations worldwide, emphasizing its significant role in the life sciences and advanced technologies sectors.
Avantor, Inc. (NYSE: AVTR) has successfully completed the acquisition of Ritter GmbH, enhancing its capabilities in clinical diagnostics and life sciences research. This strategic move integrates Ritter's liquid dispensing technology with Avantor's lab automation solutions, aiming to deliver greater value to biopharma and healthcare customers. Ritter, known for high-quality robotic and liquid handling consumables, specializes in various diagnostic applications, further bolstering Avantor's extensive portfolio. The acquisition received all necessary regulatory approvals.
Avantor (NYSE: AVTR) announced on June 1, 2021, the acquisition of RIM Bio, a prominent Chinese producer of single-use bioprocess bags for biopharmaceutical manufacturing. This strategic purchase enhances Avantor's capacity in the AMEA region, establishing its first single-use production plant there. The acquisition aims to leverage RIM Bio's proprietary technologies, thereby expanding Avantor's offerings in bioproduction and addressing increasing global demand in the biopharma sector. The move aligns with Avantor's ongoing investments in China.
Avantor, a global leader in mission-critical products for life sciences, will participate in the Goldman Sachs 42nd Annual Global Healthcare Conference on June 8, 2021. Michael Stubblefield, President and CEO, will represent the company starting at 9:40 a.m. EDT. A live webcast of the event will be available on Avantor's investor relations website, with a replay accessible until June 30, 2021.
Avantor serves over 225,000 locations across 180 countries, providing essential services across various industries, including biopharma and healthcare.